NASDAQ·In Vitro & In Vivo Diagnostic Substances
VRAX
Virax Biolabs Group Ltd
Virax Biolabs Group Ltd (ticker: VRAX) is an NASDAQ-listed in vitro & in vivo diagnostic substances company. DredgeCap's structured extraction of VRAX's SEC filings surfaces 3 active risk signals, including 2 late-filing signals, and 1 auditor-change signal. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.